Lixisenatide
Generic Name: lixisenatide
Manufactured by SANOFI-AVENTIS US. Dosage form: SOLUTION. Route: SUBCUTANEOUS. Active ingredients: LIXISENATIDE (0.3MG/3ML (0.1MG/ML)). Application: BLA208471.
Overview
Manufactured by SANOFI-AVENTIS US. Dosage form: SOLUTION. Route: SUBCUTANEOUS. Active ingredients: LIXISENATIDE (0.3MG/3ML (0.1MG/ML)). Application: BLA208471.
Dosage
Available as solution for subcutaneous use.
Related Medications
Dostarlimab-gxly
dostarlimab-gxly
Manufactured by GLAXOSMITHKLINE LLC. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: DOSTARLIMAB-GXLY (500MG/10ML). Application: BLA761223.
Zaleplon
zaleplon
gamma-Aminobutyric Acid A Receptor Agonist [EPC]
DESCRIPTION Zaleplon is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class. The chemical name of zaleplon is N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide. Its molecular formula is C 17 H 15 N 5 O, and its molecular weight is 305.34. The structural formula is shown below. Zaleplon USP is a white to off-white powder that is practically insoluble in water and sparingly soluble in alcohol or propylene glycol.
Nausea/morning Sickness Drops
nausea/morning sickness drops
Non-Standardized Food Allergenic Extract [EPC]
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.